induced pain flare after palliative radiotherapy for bone
8.Cleeland CS. The measurement of pain from metastatic bone disease: capturing the patient's experience. Clin Cancer Res 12(20 Pt 2):
9.Colella J, Scrofine S, Galli B,
10.Depuy V, Anstrom KJ, Castel LD, Schulman KA, Weinfurt KP, Saad F. Effects of skeletal morbidities on longitudinal patient- reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer 15(7):
11.Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, Wong GY, Sloan JA, Novotny PJ, Petersen IA, Beres RA, Regge D, Capanna R, Saker MB, Gronemeyer DH, Gevargez A, Ahrar K, Choti MA, de Baere TJ, Rubin J. Percutaneous
12.Hadi S, Fan G, Hird AE,
13.Halabi S, Vogelzang NJ, Kornblith AB, Ou SS, Kantoff PW, Dawson NA, Small EJ. Pain predicts overall survival in men with metastatic
14.Harris K, Pugash R, David E, Yee A, Sinclair E, Myers J, Chow E. Percutaneous cementoplasty of lytic metastasis in left acetabulum. Curr Oncol 14(1):
15.Harris K, Li K, Flynn C, Chow E. Worst, average or current pain in the brief pain inventory: Which should be used to calculate the response to palliative radiotherapy in patients with bone metastases? Clinical Oncology 19(7):
16.Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M, III, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M. Randomized trial of short- versus
17.Hong SJ, Cho KS, Choi HY, Ahn H, Kim CS, Chung BH. A prospective, multicenter,
18.Janjan NA, Payne R, Gillis T, Podoloff D, Libshitz HI, Lenzi R, Theriault R, Martin C, Yasko A. Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. J Pain Symptom Manage 16(3):
19.Kornblith AB, Herndon JE, Zuckerman E, Godley PA, Savarese D, Vogelzang NJ. The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility study. Ann Oncol 12(5):
20.Loblaw A, Chow E, Panzarella T, Tsao M, Barnes EA, Sinclair E, Farhadian M, Danjoux C. Dexamethasone for the prophylaxis of
21.Lothman H, Heatley S, Lipton A. Zoledronic acid (zol) provides
22.Mystakidou K, Katsouda E, Parpa E, Kouskouni E, Chondros C, Tsiatas ML, Galanos A, Vlahos L. A prospective randomized controlled clinical trial of zoledronic acid for bone metastases. Am J Hosp Palliat Care 23(1):
23.Nishio M, Sano M, Tamaki Y, Fujii H, Shima Y, Fujimoto H, Kubo A, Koizumi K, Tokuda Y, Adachi S, Sumiyoshi Y, Hasegawa T, Eguchi K. [A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony
17 | 18 |